How to Buy Fusion Pharmaceuticals Stock
Fusion Pharmaceuticals Inc
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines.
Fusion Pharmaceuticals stock last closed at $21.42, up 0.47% from the previous day, and has increased 462.2% in one year. It has overperformed other stocks in the Biotechnology industry by 4.85 percentage points. Fusion Pharmaceuticals stock is currently +827.27% from its 52-week low of $2.31, and -0.6% from its 52-week high of $21.55.
At the moment, there are 84.69M shares of FUSN outstanding. The market value of FUSN is $1.81B. In the past 24 hours, 1.87M FUSN shares were traded.
How to Buy Fusion Pharmaceuticals Stock
Wondering how to invest in Fusion Pharmaceuticals stock? Here's how.
- Figure out where to buy Fusion Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Fusion Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Choose your payment method and add your info.
- Research Fusion Pharmaceuticals stock: The Fusion Pharmaceuticals ticker symbol is FUSN. Is Fusion Pharmaceuticals stock a good investment? Should you buy shares of FUSN? How do FUSN's underlying business fundamentals look? Do top analysts think Fusion Pharmaceuticals is a good buy? Why has FUSN's stock price moved recently? (Hint: Our stock research website can help you understand if FUSN is a good stock to buy).
- Execute your FUSN purchase: Decide if you will purchase FUSN shares at the current market price or use a limit order to buy FUSN shares at a specific price.
- Keep an eye on your FUSN investment: Create a watchlist to the latest updates on your new investment in Fusion Pharmaceuticals shares.
Step 1: Figure out where to buy Fusion Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy FUSN stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal information so you are able to invest in FUSN today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on apps for stock market, your next step is to transfer the money for your investment:
Check out the video below for more details depositing funds into your new brokerage account.
Step 4: Research Fusion Pharmaceuticals stock
Once you have decided on the best place to buy Fusion Pharmaceuticals stock, it's critical to research their stock before you buy, so you can comprehend the risk and opportunity.
Fusion Pharmaceuticals stock quick numbers
FUSN Zen Score
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on FUSN's stock page.
Is FUSN stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge FUSN's true value.
Using relative valuations metrics:
- FUSN could be overvalued based on its P/B ratio of 8.15x, relative to Biotechnology industry P/B ratio of 5.93x
You can access additional valuation analysis on FUSN's stock here.
FUSN Financial Health Overview
Signs that FUSN is financially healthy:
- There are more short-term assets than short-term liabilities on the FUSN balance sheet.
- FUSN has cash burn of 85692000. It has enough cash and short-term investments to cover this for at least one year.
- FUSN has $234.93M in cash and short term investments. This is enough to cover its annual cash burn of $85.69M.
- There are more short-term assets than long-term liabilities on the FUSN balance sheet.
- Total FUSN debt is lower than 5 years ago, relative to shareholder equity.
- FUSN has a low debt to equity ratio of 0.29.
Signs that FUSN is not financially healthy:
- FUSN profit margin has gone up by 14.08 percentage points in the past year, but the company is still unprofitable.
Is FUSN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 8 Equities analysts who track FUSN, the consensus analyst rating on FUSN is a Hold
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent FUSN Analyst Recommendations
Faisal Khurshid, a bottom 27% analyst from Leerink Partners downgrades FUSN to a hold rating and raises their FUSN price target from $17.00 to $21.00, on Mar 19, 2024.
Rahul Sarugaser, a top 13% analyst from Raymond James maintains FUSN with a strong buy rating and raises their FUSN price target from $15.00 to $16.00, on Jan 5, 2024.
Raymond James's Rahul Sarugaser raised their price target on Fusion Pharmaceuticals (NASDAQ: FUSN) by 6.7% from $15 to $16 on 2024/01/05. The analyst maintained their Strong Buy rating on the stock.
Sarugaser explained that their price target increase followed Fusion Pharmaceuticals's "clinical and manufacturing updates ahead of the JPMorgan Healthcare conference scheduled for 2024/01/08 to 11."
There has recently been "a flurry of M&As in the radiopharmaceuticals and targeted oncology spaces," the analyst noted, predicting that "any move on Fusion Pharmaceuticals would come at a significant premium."
Jeff Jones, a top 10% analyst from Oppenheimer maintains FUSN with a buy rating and raises their FUSN price target from $13.00 to $15.00, on Jan 5, 2024.
You can dive deeper into what analysts are forecasting on the Fusion Pharmaceuticals stock forecast page.
FUSN Technical Indicators
FUSN Growth Numbers
Last year, FUSN revenue was $2.07M. During the last two year, FUSN's revenue has gone up by 19.84% per year. This was slower than the Biotechnology industry average of 28.88%.
Learn more about FUSN's earnings and revenue performance here.
Are FUSN executives and large shareholders buying or selling the stock?
Over the last 12 months, insiders at FUSN have not bought or sold any shares.
Research more about who owns FUSN shares here.
Does FUSN stock generate passive income?
No, Fusion Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about FUSN
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your FUSN purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, use a limit order.
Hit the Open button and eToro will place your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
Step 6: Keep an eye on your FUSN investment
Now that you own some FUSN stock, you'll want to keep up with your shares.
Add FUSN to a watchlist to track the latest developments regarding your FUSN stock.
FUSN Feed
How to Buy Stock in Fusion Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Fusion Pharmaceuticals:
- Figure out where to buy Fusion Pharmaceuticals stock
- Open a brokerage account
- Put funds into your investment account
- Research Fusion Pharmaceuticals stock
- Execute your FUSN purchase
- Keep an eye on your FUSN investment
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get updates on your investment in Fusion Pharmaceuticals, add FUSN to your watchlist by clicking the button below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.